Chris Coffin is a partner with Pendley, Baudin & Coffin, L.L.P., located in New Orleans, Louisiana. He has years of experience and background in litigating complex cases involving defective pharmaceuticals and medical devices, environmental contamination, product liability, toxic torts and consumer fraud claims. In addition to being a registered nurse for over twenty-four (24) years, as the leader of Pendley, Baudin & Coffin’s pharmaceutical and medical device litigation practice, Chris has been actively prosecuting cases against pharmaceutical and medical device manufacturers for over seventeen (17) years. Chris has been heavily involved in multiple class action and mass tort cases throughout the United States. He has served as Co-Lead Counsel in several MDL actions, including the following: In re: Taxotere (Docetaxel) Products Liability Litigation, in the Eastern District of Louisiana; In re: Benicar (Olmesartan) Products Liability Litigation, in the District of New Jersey; In re: Celexa and Lexapro Products Liability Litigation, in the Eastern District of Missouri; In re: Celexa and Lexapro Marketing and Sales Practices Litigation, in the District of Massachusetts; and In re: Atlas Roofing Corporation Chalet Shingle Products Liability Litigation, in the Northern District of Georgia. In addition, Chris was a member of the PSC in the In re: Paxil Products Liability Litigation, in the Central District of California; In re: Zoloft Products Liability Litigation, in the Eastern District of Pennsylvania; In re: Effexor Products Liability Litigation, in the Eastern District of Pennsylvania; In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, in the District of Minnesota; and In re: Lipitor (Atorvastatin Calcium) Marketing, Sales Practices and Product Liability Litigation, in the District of South Carolina.
Chris currently serves as the Co-Chair of the AAJ’s Benicar (Azor) Tribenzor Litigation Group. He is also a member of AAJ’s Leaders Forum; Products Liability Section; Section on Toxic, Environmental, and Pharmaceutical Torts (STEP); AAJ’s Class Action Litigation Group; the Louisiana Association for Justice (LAJ); and the American Association of Nurse Attorneys. He lectures nationwide and has written numerous articles on pharmaceutical litigation and defective products in the context of mass torts and class actions.